Skip to main content
Tulio Rodriguez, MD, Hematology, Zion, IL, City of Hope Chicago

TulioERodriguezMD

Hematology Zion, IL

Hematologic Oncology

Director of Hematology, Bone Marrow Transplant and Cellular Therapy Program at City of Hope Chicago

Overview of Dr. Rodriguez

Dr. Tulio Rodriguez is a hematologist/oncologist who specializes on hematologic malignancies and bone marrow transplantation. He completed his training in Hematology/Oncology and Bone Marrow Transplantation at the University of Texas Health Science Center in San Antonio, Texas. He has held faculty appointments at Texas A&M Health Science Center, RUSH University School of Medicine, and became Professor of Medicine at Loyola University Stritch School of Medicine in Illinois where he practiced for 14 years. He is currently a Professor of Medicine at Rosalind Franklin University of Medicine and Science in North Chicago, IL.

Dr. Rodriguez has published and lectured widely on a range of medical and bone marrow transplant topics. He has devoted much of his research career to the study of hematologic malignancies and hematopoietic stem cell transplantation. He is a member of the Center for International Blood and Marrow Transplant Research and is an advocate for National Institutes of Health research funding through the American Society of Hematology Advocacy Leadership Institute.

Dr. Rodriguez is board certified in Hematology by the American Board of Internal Medicine Subspecialty and is currently the Director of Hematology, Bone Marrow Transplant and Cellular Therapy Program at City of Hope Chicago.

Education & Training

  • University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of Medicine
    University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1993 - 1996
  • VA Caribbean Healthcare System
    VA Caribbean Healthcare SystemResidency, Internal Medicine, 1990 - 1993
  • Pontificia Universidad Católica Madre y Maestra
    Pontificia Universidad Católica Madre y MaestraClass of 1987

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2000 - 2026
  • TX State Medical License
    TX State Medical License 1996 - 2025
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Busulfan, Melphalan, and Bortezomib Compared to Single Agent High-Dose Melphalan As a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Mu...
    Tulio E Rodriguez, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

  • Advocate Lutheran General to Host Marrow Registry Drive
    Advocate Lutheran General to Host Marrow Registry DriveNovember 12th, 2018
  • On the Holiday to Give Thanks, 20-Year-Old Marcela Received a Cancer Diagnosis
    On the Holiday to Give Thanks, 20-Year-Old Marcela Received a Cancer DiagnosisAugust 20th, 2018
  • New Drug Dramatically Improves Survival in Hodgkin Lymphoma Patients
    New Drug Dramatically Improves Survival in Hodgkin Lymphoma PatientsJune 27th, 2012
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • BCBS Blue Card PPO
    BCBS Illinois PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Great West PPO
    HealthLink PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment